Expression of a Human SOCS Protein, HSOCP-1, in Peripheral Blood Eosinophils from Patients with Atopic Dermatitis

2004 ◽  
Vol 134 (1) ◽  
pp. 2-6 ◽  
Author(s):  
Kaoru Ogawa ◽  
Mikito Itoh ◽  
Masami Miyagawa ◽  
Takeshi Nagasu ◽  
Yuji Sugita ◽  
...  
PROTEOMICS ◽  
2005 ◽  
Vol 5 (7) ◽  
pp. 1987-1995 ◽  
Author(s):  
Sun Woo Yoon ◽  
Tae Yoon Kim ◽  
Moon Hee Sung ◽  
Chul Joong Kim ◽  
Haryoung Poo

2003 ◽  
Vol 131 (Suppl. 1) ◽  
pp. 26-33 ◽  
Author(s):  
Ryoichi Hashida ◽  
Kaoru Ogawa ◽  
Masami Miyagawa ◽  
Yuji Sugita ◽  
Eiki Takahashi ◽  
...  

2008 ◽  
Vol 13 (9) ◽  
pp. 588-589
Author(s):  
U. Raap ◽  
N. Deneka ◽  
C. Goltz ◽  
M. Bruder ◽  
H. Renz ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shannon Wongvibulsin ◽  
Nishadh Sutaria ◽  
Suraj Kannan ◽  
Martin Prince Alphonse ◽  
Micah Belzberg ◽  
...  

AbstractAtopic dermatitis (AD) often presents more severely in African Americans (AAs) and with greater involvement of extensor areas. To investigate immune signatures of AD in AAs with moderate to severe pruritus, lesional and non-lesional punch biopsies were taken from AA patients along with age-, race-, and sex-matched controls. Histology of lesional skin showed psoriasiform dermatitis and spongiotic dermatitis, suggesting both Th2 and Th17 activity. Gene Set Variation Analysis showed upregulation of Th2 and Th17 pathways in both lesional versus non-lesional and lesional versus control (p < 0.01), while Th1 and Th22 upregulation were observed in lesional versus control (p < 0.05). Evidence for a broad immune signature also was supported by upregulated Th1 and Th22 pathways, and clinically may represent greater severity of AD in AA. Furthermore, population-level analysis of data from TriNetX, a global federated health research network, revealed that AA AD patients had higher values for CRP, ferritin, and blood eosinophils compared to age-, sex-, and race-matched controls as well as white AD patients, suggesting broad systemic inflammation. Therefore, AA AD patients may feature broader immune activation than previously thought and may derive benefit from systemic immunomodulating therapies that modulate key drivers of multiple immune pathways.


2008 ◽  
Vol 121 (2) ◽  
pp. S15-S15
Author(s):  
Y ITO ◽  
T MAKINO ◽  
Y ADACHI ◽  
H HIGASHIYAMA ◽  
T SHIMIZU ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document